Care Access Hoboken — Hoboken, New Jersey

Care Access Hoboken is a clinical research site located in Hoboken, New Jersey, United States 07030.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Care Access Hoboken has participated in 10 clinical trials with 7 currently active.

Therapeutic areas: Psoriasis, Overweight or Obesity, Atopic Dermatitis.

Sponsors: Eli Lilly and Company, Novartis Pharmaceuticals, Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Hoboken

Browse all research sites in New Jersey · View every site in Hoboken

• University Reproductive Associates
• Hoboken University Medical Center (MSSM satellite site)
• Novo Nordisk Investigational Site
• Hudson Dermatology and Skin Cancer Center
• Hoboken Univ Med Ctr
• Orthodontia Studio
• Care Access Research /ID# 218476
• CTOR
• Octapharma USA
• Care Access - Hoboken /ID# 264066
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Care Access Hoboken?

Care Access Hoboken has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Care Access Hoboken conducted?

Care Access Hoboken has 10 clinical trials on record, with 7 currently active. Their work covers Psoriasis, Overweight or Obesity, Atopic Dermatitis.

Is Care Access Hoboken accredited by Crixeo Clinical Trials?

Care Access Hoboken has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Care Access Hoboken?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.